Brief: Discover the BCSTE-HM Hospital Sewage Treatment Solution, designed to tackle high-risk hospital wastewater with pathogens, pharmaceutical residues, and disinfectant byproducts. Our portable system combines medical-grade technology and strict compliance for safe purification, infection control, and sustainability.
Related Product Features:
Multi-barrier process with 0.2mm fine screen filtration removes 99% of solids.
MBR + AOP hybrid system degrades 98%+ BOD and breaks down 90%+ pharmaceutical residues.
Dual-stage disinfection with UV-C and chlorine dioxide ensures 99.99% pathogen elimination.
Compliant with China's GB 18466-2005, EU 91/271/EEC, and U.S. EPA 40 CFR Part 133 standards.
Silent operation (<60dB) and modular design fit limited hospital spaces.
Smart PLC monitoring tracks pathogens, chlorine, and flow with instant alarms.
Durable 316L stainless steel construction ensures 15+ years of service.
Optional ion exchange removes 95%+ radioactive isotopes for radiology departments.
Faqs:
What makes hospital sewage treatment different from other wastewater treatments?
Hospital sewage contains high-risk pathogens, pharmaceutical residues, and disinfectant byproducts, requiring specialized processes like MBR + AOP hybrid systems and dual-stage disinfection to ensure safety and compliance.
How does the BCSTE-HM system handle pharmaceutical residues?
The Advanced Oxidation Process (AOP) using UV/H₂O₂ breaks down 90%+ pharmaceutical residues, such as penicillin, preventing drug-resistant bacteria spread.
What certifications does the BCSTE-HM system meet?
The system is certified to China's GB 18466-2005 (Class 1A), EU 91/271/EEC, and U.S. EPA 40 CFR Part 133, ensuring global healthcare compliance.